- 14. Cash and cash equivalents
- 15. Trade accounts receivable
- 16. Inventories
- 17. Other current and non-current assets
- 18. Property, plant and equipment
- 19. Goodwill and other intangible assets
- 20. Accrued expenses
- 21. Other liabilities
- 22. Debt and capital lease obligations
- 23. Senior Notes
- 24. Mandatory Exchangeable Bonds
- 25. Trust preferred securities
- 26. Pensions and similar obligations
- 27. Noncontrolling interest
- 28. Fresenius SE & Co. KGaA shareholders’ equity
- 29. Other comprehensive income (loss)
27. Noncontrolling interest
Noncontrolling interest subject to put provisions
The Fresenius Group has potential obligations to purchase the noncontrolling interests held by third parties in certain of its consolidated subsidiaries. These obligations are in the form of put provisions and are exercisable at the third-party owners’ discretion within specified periods as outlined in each specific put provision. If these put provisions were exercised, the Fresenius Group would be required to purchase all or part of third-party owners’ noncontrolling interests at the appraised fair value at the time of exercise.
Noncontrolling interest subject to put provisions changed as follows:
€ in millions | 2012 |
---|---|
Noncontrolling interest subject to put provisions as of January 1, 2012 | 317 |
Noncontrolling interest subject to put provisions in profit | 72 |
Purchase of noncontrolling interest subject to put provisions | 116 |
Dividend payments | -87 |
Currency effects, first-time consolidations and other changes | -20 |
Noncontrolling interest subject to put provisions as of December 31, 2012 | 398 |
As of December 31, 2012 and 2011, €173 million and €88 million, respectively, were exercisable. One put option was exercised for a total consideration of €2 million in 2012.
Noncontrolling interest not subject to put provisions
As of December 31, noncontrolling interest not subject to put provisions in the Fresenius Group was as follows:
€ in millions | 2012 | 2011 |
---|---|---|
Noncontrolling interest not subject to put provisions in Fresenius Medical Care AG & Co. KGaA |
4,692 | 4,254 |
Noncontrolling interest not subject to put provisions in VAMED AG | 33 | 28 |
Noncontrolling interest not subject to put provisions in the business segments | ||
Fresenius Medical Care | 201 | 123 |
Fresenius Kabi | 86 | 63 |
Fresenius Helios | 111 | 136 |
Fresenius Vamed | 2 | 2 |
Total noncontrolling interest not subject to put provisions | 5,125 | 4,606 |
Due to the maturity of the Mandatory Exchangeable Bonds on
August 14, 2011, Fresenius
SE & Co. KGaA’s shareholding in
Fresenius
Medical Care
AG & Co. KGaA (FMC-AG & Co. KGaA)
was reduced by 15,722,644 ordinary shares to 30.4% of the
ordinary share capital. From November 2011 to February
2012, Fresenius
SE & Co. KGaA purchased 3,500,000 ordinary
shares of FMC-AG & Co. KGaA. Therewith, Fresenius
SE &
Co. KGaA’s shareholding in FMC-AG & Co. KGaA amounted to
31.2% of the ordinary share capital as of December 31,
2012.
Noncontrolling interest not subject to put provisions changed as follows:
€ in millions | 2012 |
---|---|
Noncontrolling interest not subject to put provisions as of January 1, 2012 | 4,606 |
Noncontrolling interest not subject to put provisions in profit | 734 |
Stock options | 79 |
Purchase of noncontrolling interest not subject to put provisions | 56 |
Dividend payments | -204 |
Purchase of ordinary shares of FMC-AG & Co. KGaA | -43 |
Currency effects, first-time consolidations and other changes | -103 |
Noncontrolling interest not subject to put provisions as of December 31, 2012 |
5,125 |
26. Pensions and similar obligations
28. Fresenius SE & Co. KGaA shareholders’ equity